Home › Lung Diseases › Colorado › Denver
Lung Diseases clinical trials in Denver, CO
4 studies for Lung Diseases are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
- National Jewish Health Medical Center, Denver
American Lung Association (ALA) Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- National Jewish Health, Denver
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RecruitingPhase 2
- National Jewish Health, Denver
Deep Functional Phenotyping of the ALA Lung Health Cohort
RecruitingObservational studyHealthy volunteers welcome
- National Jewish Health, Denver
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Multiple Myeloma27 studies
- Non-Small Cell Lung Cancer27 studies
- Colorectal Cancer23 studies
- Prostate Cancer19 studies
- Melanoma19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.